{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T21:02:18Z","timestamp":1763499738655,"version":"3.37.3"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We describe the successful use of rituximab for the treatment of IgA nephropathy in a patient with recessive dystrophic epidermolysis bullosa. To our knowledge, this is the first reported case in the literature.<\/jats:p>","DOI":"10.1111\/ced.15228","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T09:08:08Z","timestamp":1650013688000},"page":"1588-1590","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Successful use of rituximab, an anti-CD20 monoclonal antibody, to treat IgA nephropathy in a patient with recessive dystrophic epidermolysis bullosa"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-6082","authenticated-orcid":false,"given":"Manrup Kaur","family":"Hunjan","sequence":"first","affiliation":[{"name":"Adult Epidermolysis Bullosa Service Solihull Hospital University Hospitals Birmingham NHS Trust Birmingham UK"},{"name":"College of Medical and Dental Sciences University of Birmingham Birmingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8281-6123","authenticated-orcid":false,"given":"Ajoy","family":"Bardhan","sequence":"additional","affiliation":[{"name":"Adult Epidermolysis Bullosa Service Solihull Hospital University Hospitals Birmingham NHS Trust Birmingham UK"},{"name":"Institute of Clinical Sciences University of Birmingham Birmingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Harper","sequence":"additional","affiliation":[{"name":"Adult Epidermolysis Bullosa Service Solihull Hospital University Hospitals Birmingham NHS Trust Birmingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Langman","sequence":"additional","affiliation":[{"name":"Department of Cellular Pathology Queen Elizabeth Hospital University Hospitals Birmingham NHS Trust Birmingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bamidele","family":"Ajayi","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine Heartlands and Solihull Hospitals University Hospitals Birmingham NHS Trust Birmingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Suresh","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine Heartlands and Solihull Hospitals University Hospitals Birmingham NHS Trust Birmingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4351-7467","authenticated-orcid":false,"given":"Adrian H. M.","family":"Heagerty","sequence":"additional","affiliation":[{"name":"Adult Epidermolysis Bullosa Service Solihull Hospital University Hospitals Birmingham NHS Trust Birmingham UK"},{"name":"Institute of Clinical Sciences University of Birmingham Birmingham UK"},{"name":"Institute of Ageing and Inflammation University of Birmingham Birmingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,8,1]]},"reference":[{"key":"2023041114212061800_","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41572-020-0210-0","article-title":"Epidermolysis bullosa","volume":"6","author":"Bardhan","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2023041114212061800_","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0272-6386(04)00935-7","article-title":"Inherited epidermolysis bullosa and the risk of death from renal disease: experience of the national epidermolysis bullosa registry","volume":"44","author":"Fine","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2023041114212061800_","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00467-007-0577-0","article-title":"End-stage renal disease secondary to IgA nephropathy in recessive dystrophic epidermolysis bullosa: a case report","volume":"23","author":"Tammaro","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"2023041114212061800_","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10157-019-01700-1","article-title":"New strategies and perspectives on managing IgA nephropathy","volume":"23","author":"Selvaskandan","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"2023041114212061800_","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaad.2008.09.035","article-title":"Epidermolysis bullosa and the risk of life-threatening cancers: the national EB registry experience, 1986\u20132006","volume":"60","author":"Fine","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"2023041114212061800_","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/nep.12722","article-title":"Rituximab for recurrent IgA nephropathy in kidney transplantation: a report of three cases and proposed mechanisms","volume":"22","author":"Chancharoenthana","year":"2017","journal-title":"Nephrology (Carlton)"},{"key":"2023041114212061800_","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.det.2010.01.014","article-title":"Genitourinary tract involvement in epidermolysis bullosa","volume":"28","author":"Almaani","year":"2010","journal-title":"Dermatol Clin"},{"key":"2023041114212061800_","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0151-9638(04)93806-9","article-title":"Recessive dystrophic epidermolysis bullosa (Hallopeau-Siemens) with IgA nephropathy: 4 cases","volume":"131","author":"Farhi","year":"2004","journal-title":"Ann Dermatol Venereol"},{"key":"2023041114212061800_","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40744-019-00183-6","article-title":"Risk of malignancies in patients with rheumatoid arthritis treated with rituximab: analyses of global postmarketing safety data and long-term clinical trial data","volume":"7","author":"Emery","year":"2020","journal-title":"Rheumatol Ther"},{"key":"2023041114212061800_","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/annrheumdis-2016-209925","article-title":"Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis","volume":"76","author":"van Daalen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2023041114212061800_","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1038\/s41598-020-63170-w","article-title":"The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: a network meta-analysis","volume":"10","author":"Tan","year":"2020","journal-title":"Sci Rep"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ced.15228","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ced.15228","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/47\/8\/1588\/49839076\/ced1588.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/47\/8\/1588\/49839076\/ced1588.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T01:36:55Z","timestamp":1700444215000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/47\/8\/1588\/6692963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":11,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,1]]},"published-print":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.1111\/ced.15228","relation":{},"ISSN":["1365-2230","0307-6938"],"issn-type":[{"type":"electronic","value":"1365-2230"},{"type":"print","value":"0307-6938"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2022,8,1]]},"assertion":[{"value":"2022-04-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}